Visual Rehabilitation of Patients With Myopic Maculopathy

This study has been completed.
Information provided by:
University of Roma La Sapienza Identifier:
First received: November 18, 2010
Last updated: NA
Last verified: February 2010
History: No changes posted
The Visual Pathfinder (LACE inc.) offers a non- invasive, patient- centered visual rehabilitation system based on an acoustic biofeedback. The investigators wanted to evaluate its usefulness in the improvement of visual function in visually impaired patients with high myopia.

Condition Intervention
Myopic Maculopathy
Behavioral: biofeedback training

Study Type: Interventional

Further study details as provided by University of Roma La Sapienza:

Primary Outcome Measures:
  • improvement of visual performance

Secondary Outcome Measures:
  • improvement of visual acuity, retinal sensitivity, fixation stability

Arms Assigned Interventions
Experimental: biofeedback Behavioral: biofeedback training


Ages Eligible for Study:   35 Years to 57 Years
Genders Eligible for Study:   Both

Inclusion Criteria:

  • high myopia (range 9-15 D) visited at the Outpatient Medical Retina's Hospital A. Fiorini Terracina (LT), University of Rome "La Sapienza", Polo Pontino. The diagnosis of myopic maculopathy was made on the basis of a comprehensive ophthalmological evaluation which included: biomicroscopic examination of anterior and posterior segment, fluorescein angiography (FAG) (Heidelberg HRA-2, FA module Heidelberg, Germany), optical coherence tomography (OCT), Spectral Domain (Heidelberg HRA-2, OCT module Heidelberg, Germany) and microperimetry with microperimeter MP-1 (Nidek Technologies, Padova, Italy).

Exclusion Criteria:

  • The investigators have excluded patients with other eye diseases (glaucoma, AMD, retinal detachment, etc.), uncooperative patients and persons with opacity of the dioptric media.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01244074

University La Sapienza, Polo Pontino
Latina, Italy, 04100
Sponsors and Collaborators
University of Roma La Sapienza
  More Information

No publications provided Identifier: NCT01244074     History of Changes
Other Study ID Numbers: BIO0210
Study First Received: November 18, 2010
Last Updated: November 18, 2010
Health Authority: Italy: University La Sapienza processed this record on December 01, 2015